Market›Health Care›Pharmaceuticals›Pharmaceuticals
SANDOZ GROUP AG ADR

SDZNY

$80.96Oct 04, 2023 – Apr 24, 2026
Health CarePharmaceuticals$35.39B
MVM
+$60.6M
TD Variance
2.214

Every news event mapped to its market reaction — 50 events, 31 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2026-02-25+6.3%earningsSeeking AlphaSandoz Group AG 2025 Q4 - Results - Earnings Call Presentation
2026-02-25+6.3%earningsSeeking AlphaSandoz Group AG Non-GAAP EPS of $3.64 beats by $0.38, revenue of $11.1B beats by $20M
2026-02-25+6.3%earningsSeeking AlphaSandoz Group AG (SDZNY) Q4 2025 Earnings Call Transcript
2025-10-30+6.3%earningsSeeking AlphaSandoz Group AG (SDZNY) Q3 2025 Sales/Trading Call Transcript
2025-10-30+6.3%earningsSeeking AlphaSandoz Group AG (SDZNY) Q3 2025 Sales/ Trading Statement Call - Slideshow
2023-10-15+4.6%newsZacks Investment ResearchSandoz Group AG Sponsored ADR (SDZNY) - Zacks Investment Research
2026-03-10-4.5%newsSeeking AlphaSandoz creates biosimilar unit to benefit from major patent cliff
2026-03-10-4.5%newsYahoo FinanceSGIOY vs. SDZNY: Which Stock Should Value Investors Buy Now? - Yahoo Finance
2025-08-07+4.4%earningsSeeking AlphaSandoz Group AG 2025 Q2 - Results - Earnings Call Presentation
2025-08-07+4.4%earningsSeeking AlphaSandoz Group AG (SDZNY) Q2 2025 Earnings Call Transcript
2026-04-15-4.4%newsMSNSGIOY vs. SDZNY: Which stock is the better value option? - MSN
2023-10-05+3.1%analysteToroSandoz Group AG-ADR (SDZNY) Stock Price, News & Analyst Forecast - eToro
2023-10-05+3.1%earningsMarketBeatSandoz Group (SDZNY) Stock Price, News & Analysis - MarketBeat
2025-06-17+2.9%newsSeeking AlphaHow are generic drugmakers reacting to Trumps push for domestic production?
2026-01-14+2.7%newsSeeking AlphaSandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
2025-05-02+2.7%earningsSeeking AlphaSandoz Group AG (SDZNY) Q1 2025 Earnings Call Transcript
2026-01-13+2.7%newsSeeking AlphaSandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
2024-08-08-2.4%earningsSeeking AlphaSandoz Group Non-GAAP EPS of $1.12, revenue of $5B
2024-08-08-2.4%earningsSeeking AlphaSandoz Group AG (SDZNY) Q2 2024 Earnings Call Transcript
2024-08-08-2.4%earningsSeeking AlphaSandoz Group AG 2024 Q2 - Results - Earnings Call Presentation
2025-04-29-2.3%expansionSeeking AlphaSandoz inks agreement with Shanghai Henlius for Bristol Yervoy biosimilar
2025-04-14+2.2%legalSeeking AlphaAmgen faces antitrust lawsuit from Sandoz over Enbrel patents
2025-01-10+2.1%newsSeeking AlphaIntra-Cellular settles Caplyta patent dispute with Sandoz
2026-04-10+2.0%expansionClinical Trials ArenaOCT Europe 2026: tackling clinical trial complexities with innovation and partnerships
2025-03-05-2.0%earningsSeeking AlphaSandoz Group AG Non-GAAP EPS of $2.71, revenue of $10.36B; initiates FY25 outlook
2026-03-11-1.7%newsSeeking AlphaSandoz: Well-Managed Generic Drug Producer, But Fairly Valued
2024-09-13-1.7%newsSeeking AlphaSandoz Group: Moving To A 'Hold' After A 50% Move
2025-02-24-1.7%expansionSeeking AlphaSandoz launches biosimilar Pyzchiva in U.S. for all approved Stelara indications
2026-04-17+1.5%newsGlobeNewswireMiddle East and Africa Biosimilars Market Trends Report 2026-2035, Profiles of AbbVie, Amgen, Biocon, Celltrion, Dr. Reddy's, Pfizer, Roche, Samsung, Sandoz, Teva, Viatris
2025-12-03-1.3%analystYahoo FinanceSandoz Group AG Sponsored ADR (SDZNY) Upgraded to Buy: Here's Why - Yahoo Finance
2025-11-04-1.2%M&ASeeking AlphaEvotec signs deal with Sandoz for Just - Evotec Biologics site
2025-03-04+1.1%newsSeeking AlphaGeneric drugmakers could see negative impact from higher Chinese tariffs
2026-03-26+1.0%newsZacksSGIOY vs. SDZNY: Which Stock Is the Better Value Option?
2026-03-30+1.0%analystZacksAll You Need to Know About Sandoz Group AG Sponsored ADR (SDZNY) Rating Upgrade to Buy
2026-03-30+1.0%analystYahoo FinanceAll You Need to Know About Sandoz Group AG Sponsored ADR (SDZNY) Rating Upgrade to Buy - Yahoo Finance
2026-03-30+1.0%analystbitget.comAll Essential Information on Sandoz Group AG Sponsored ADR (SDZNY) Rating Raised to Buy - bitget.com
2026-03-18-0.7%earningsGlobeNewswireAlvotech Q4 2025 and Full Year 2025 Financial Results
2026-03-18-0.7%expansionBusiness WireSamsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates
2025-03-28+0.7%analystSeeking AlphaSandoz: Upgrading To A Buy On 2028 Expectations
2024-08-21+0.6%earningsSeeking AlphaAxsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz
2026-02-05+0.6%newsSeeking AlphaSandoz: The Share Price May Have Run Its Course
2026-04-08+0.6%earningsMarketBeatEvotec Q4 Earnings Call Highlights
2025-09-09-0.5%newsSeeking AlphaRegeneron settles patent dispute with Sandoz over Eylea biosimilar
2026-04-13+0.2%newsSimply Wall St.Is It Too Late To Consider Sandoz Group (SWX:SDZ) After A 108% One-Year Rally?
2024-03-29+0.2%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Sandoz Group AG Sponsored ADR (SDZNY) - Zacks Investment Research
2025-12-04-0.1%newsSeeking AlphaMark Cuban calls for end to generic drug application fees to boost domestic manufacturing
2026-02-18-0.1%legalSeeking AlphaSandoz wins FDA nod to expand Enzeevu label to multiple retinal indications
2026-04-14-0.0%newsZacksUSNA vs. SDZNY: Which Stock Is the Better Value Option?
2026-04-14-0.0%newsYahoo Finance SingaporeUSNA vs. SDZNY: Which Stock Is the Better Value Option? - Yahoo Finance Singapore
2026-04-26—newsInsider MonkeyNovartis AG (NVS): One of the Best Low Risk High Growth Plays on the Market
tickerdossier.comtickerdossier.substack.com